186 results on '"da Fonseca, Flávio Guimarães"'
Search Results
2. Poxvirus A51R proteins regulate microtubule stability and antagonize a cell-intrinsic antiviral response
3. New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19
4. Vaccinia virus induces endoplasmic reticulum stress and activates unfolded protein responses through the ATF6α transcription factor
5. Seroprevalence of SARS-CoV-2 in hospital workers in the southern region of Minas Gerais state in Brazil: An analysis of the pre-vaccine period
6. IL-17 as a putative hallmark of intense arthralgia and age-related serum immune mediator networks during acute chikungunya fever.
7. Algorithms for predicting COVID outcome using ready-to-use laboratorial and clinical data.
8. Optimization of bioprocess of Schleiferilactobacillus harbinensis Ca12 and its viability in frozen Brazilian berries (Açai, Euterpe oleracea Mart.)
9. Will a little change do you good? A putative role of polymorphisms in COVID-19
10. A chimeric HLA-A2:β2M:Ig fusion protein for the study of virus-specific CD8+ T-cells
11. Viral Infections and Their Ability to Modulate Endoplasmic Reticulum Stress Response Pathways.
12. Short communication: a modified Vaccinia virus Ankara-based Porcine circovirus 2 vaccine elicits strong antibody response upon prime-boost homologous immunization in a preclinical model
13. Zoonotic vaccinia virus strains belonging to different genetic clades exhibit immunomodulation abilities that are proportional to their virulence
14. Taming the SARS-CoV-2-mediated proinflammatory response with BromAc®
15. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells
16. Design, development, and validation of multi-epitope proteins for serological diagnosis of Zika virus infections and discrimination from dengue virus seropositivity.
17. Concomitant helminth infection downmodulates the Vaccinia virus-specific immune response and potentiates virus-associated pathology
18. Development of Carbon Nanotubes-Based Immunogens
19. Genotypic characterization of psittacid herpesvirus isolates from Brazil
20. Tupanvirus-infected amoebas are induced to aggregate with uninfected cells promoting viral dissemination
21. 33rd Brazilian Society for Virology (SBV) 2022 Annual Meeting
22. Diversity of HLA-A2-Restricted and Immunodominant Epitope Repertoire of Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Protein: Novel Insights among N-Terminal, Central and C-Terminal Regions
23. A FACT-ETS-1 Antiviral Response Pathway Restricts Viral Replication and is Countered by Poxvirus A51R Proteins
24. In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns
25. Human in vitro eugenics: close, yet far away
26. Manipulation of unfolded protein response by zoonotic vaccinia virus strains Guarani P1 and Passatempo.
27. Short communication: a modified Vaccinia virusAnkara-based Porcine circovirus2 vaccine elicits strong antibody response upon prime-boost homologous immunization in a preclinical model
28. CD4 and CD8 T cells participate in the immune memory response against Vaccinia virus after a previous natural infection
29. Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection
30. Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients
31. Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections
32. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load
33. The 32nd Brazilian Society of Virology (SBV) 2021 Annual Meeting
34. Development of Carbon Nanotubes-Based Immunogens
35. Corrigendum: Algorithms for predicting COVID outcome using ready-to-use laboratorial and clinical data.
36. Clinical signs, diagnosis, and case reports of Vaccinia virus infections
37. The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis
38. Correction for Arantes et al., “The Large Marseillevirus Explores Different Entry Pathways by Forming Giant Infectious Vesicles”
39. Human Transgenesis: Definitions, Technical Possibilities and Moral Challenges
40. A-type inclusion bodies: a factor influencing cowpox virus lesion pathogenesis
41. Brazilian Vaccinia virus strains are genetically divergent and differ from the Lister vaccine strain
42. Immune responses to acute orthopoxvirus infections: what lessons can be learned?
43. Detection of SARS-CoV-2 through pool testing for COVID-19: an integrative review
44. 31st Brazilian Online Society for Virology (SBV) 2020 Annual Meeting
45. Zoonotic Brazilian Vaccinia virus: From field to therapy
46. Zoonotic vaccinia virus outbreaks in Brazil
47. Undetected Chikungunya virus co-infections in a Brazilian region presenting hyper-endemic circulation of Dengue and Zika
48. Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells—Comparison of Their Performances in ELISA
49. Historical Perspective and Biotechnological Trends to Block Arboviruses Transmission by Controlling Aedes aegypti Mosquitos Using Different Approaches
50. The Genome of Cowpox Virus Contains a Gene Related to Those Encoding the Epidermal Growth Factor, Transforming Growth Factor Alpha and Vaccinia Growth Factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.